Imiphumela emibi yemithi ye-Bisphosphonate

Imithi ye-bisphosphonate iye yaba yindlela ejwayelekile yokwelapha iziguli ezine- osteoporosis . Imithi ye-bisphosphonate itholakale ukwandisa amandla esithambo futhi iholele ekwenzeni okuncane ukuphuka eminyakeni emihlanu yokuqala emva kokuqala imithi. Iziguli eziningi ziye zanikezwa imithi ye-bisphosphonate (njengeFosamax, Boniva, noma i-Actonel), futhi lezi ziguli kufanele ziqaphele imiphumela engaba khona yilezi zidakamizwa.

Ukukhukhumeza isisu / ukuvutha kwamanzi

Umphumela ovame kakhulu ohlangothini oluthile lwemithi ye-bisphosphonate isisu esithukuthele. Imithi ingabangela ukuvuvukala kwesifo futhi iholele ngisho nasezikhungweni zomhlaba. Uma uthatha i-bisphosphonate ngomlomo, kunconywa ukuthi uhlale uqondile imizuzu engama-30 kuya kwangu-60 ngemuva kokuthatha imithi.

I-Osteonecrosis ye-Jaw

I-Osteonecrosis yinkinga ebangela ukuba i-bone cell cell ife. Idatha ibonisa ithuba eliphakeme lomhlathi we-osteonecrosis ezigulini ezithatha imithi ye-bisphosphonate. Lokhu kunenkinga ngokuvamile kwenzeka kubantu abathatha ama-IV amanani we-bisphosphonates, futhi ngokuvamile kubonakala ngemuva kokuba isiguli semithi ye-bisphosphonate sinokuhlinzwa kwamazinyo okubandakanya umhlathi.

I-Bone, Joint, ne-Muscle Pain

Kube khona imibiko yeziguli ezinezinhlungu ezinkulu, ezihlangene, kanye / noma zethambo emva kokuthatha imithi ye-bisphosphonate. Le nkinga ingase iphakame izinsuku, izinyanga, noma ngisho nangemva kokuqala ukwelashwa kwe-bisphosphonate.

Uma ubuhlungu obukhulu bomzimba noma ubuhlungu bomzimba buyinkinga, ukumisa imishanguzo ye-bisphosphonate kufanele kucatshangelwe. Khuluma nodokotela wakho mayelana nezimpawu zakho.

I-Femur Fracture

Ukutholakala kwezidakamizwa ze-femur ezingavamile kutholakale kwezinye iziguli ezithatha imithi ye-bisphosphonate isikhathi eside. Ucwaningo luye lwaphenya lokhu kutholakala ukuze lunqume ukuthi imithi ingaba nengxenye kulezi zinhlobo ezingavamile zokuhlukana.

Akukacaci ukuthi ukusetshenziswa kwesikhathi eside kwe-bisphosphonates kungabangela ingozi yokuhlukana, kodwa kufanele uxoxe nodokotela wakho uma kufanele uthathe le mithi isikhathi esingaphezu kweminyaka engu-4.

Fibrillation ye-Atrial

I-fibrillation ye-atrial iyinhlangano engavamile yenhliziyo engabangela ukushaya kwenhliziyo okusheshayo. Ekubuyekezeni kolwazi olulingwayo, ukufucula kwama-atrium kutholakala kaningi kwiziguli ezithatha imishanguzo ye-bisphosphonate, ikakhulukazi kwabesifazane asebekhulile. Ekubuyekezweni kolunye ulwazi, noma kunjalo, lo mbutho awubonwanga. Ngakho-ke, awaziwa ukuthi lokhu kuyi-side side effect yomuthi, kodwa i-FDA yenze isixwayiso odokotela ukuba baqaphele lokhu kubambisana okungenzeka.

Ezinye Imiphumela Ezingenzeka Ezingenzeka

Njengoba kubonisiwe, umphumela ovame kakhulu ohlangothini lomuthi we-bisphosphonate ngomlomo yisisu esithukuthele. Ezinye zalezi ezinye izinkinga kungenzeka kodwa akunakwenzeka. Iziguli ezithatha ama-bisphosphonates kufanele zixoxe nodokotela wazo ukuthi zizoqhubeka isikhathi eside kangakanani imithi. Ngaphezu kwalokho, iziguli ezinezinye izinkinga zezokwelapha ezingabangela ukungalingani kwe-electrolyte noma iziguli ezinesifo sezinso zingadinga umthamo wabo wemithi ye-bisphosphate ehlelwe. Nakuba yonke imithi inemiphumela emibi kanye nezingozi, kubalulekile ukukhumbula ukuthi kunezingozi zokungathathi imithi edingekayo.

Udokotela wakho kufanele akwazi ukukusiza ukunquma okukhethwa kukho okuhle kunikezwe izimo zakho ezithile.

Imithombo:

"Ukukhulumisana Kwangaphambi Kokubuyekezwa Kokuphepha Okuqhubekayo ku-Bisphosphonates Postmarket Ulwazi Lokuphepha Kwezidakamizwa Kwabagulayo Nabahlinzeki. Ukuphathwa Kwezokudla Nezidakamizwa (United States) 2007-10-01.